日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma

利妥昔单抗维持治疗对一线苯达莫司汀-利妥昔单抗治疗后套细胞淋巴瘤患者的益处

Wang, Yucai; Larson, Melissa C; Hwang, Steven R; Villa, Diego; Kugathasan, Laveniya; Kumar, Anita; Joseph, Ashlee; Brooks, Taylor R; Hill, Brian T; Bond, David A; Maddocks, Kami J; Nizamuddin, Imran A; Kahl, Brad S; Danilov, Alexey; Argao, Christine; Ruan, Jia; Ryan, Christine E; Merryman, Reid W; Grover, Natalie S; Khan, Nazneen B; Ouchveridze, Evguenia; Tun, Aung M; Ayyappan, Sabarish; Mou, Eric; Pongas, Georgios N; Lossos, Izidore S; Harris, Zoey I; Munoz, Javier L; Young, Philip; Portell, Craig A; Baidoun, Firas; Alhaj Moustafa, Muhamad; Reagan, Patrick M; Banaszak, Lauren G; Pophali, Priyanka A; Velayati, Arash; Greenwell, I Brian; Gerber, Drew; Jain, Preetesh; Wang, Michael L; Narkhede, Mayur S; Mehta, Amitkumar; Stack, Anthony C; Messmer, Marcus R; Bhansali, Rahul S; Barta, Stefan K; Moyo, Tamara K; Ghosh, Nilanjan; Kamdar, Manali K; Anna, Jacob; Stanisic, Alexander V; Karmali, Reem; Maurer, Matthew J; Cerhan, James R; Cohen, Jonathon B; Martin, Peter

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R marginal zone lymphoma: phase 1/2 BRUIN study

Pirtobrutinib,一种高选择性、非共价(可逆)BTKi,用于治疗复发/难治性边缘区淋巴瘤:BRUIN 1/2期研究

Patel, Krish; Vose, Julie M; Nasta, Sunita D; Brown, Jennifer R; Maddocks, Kami J; Woyach, Jennifer A; Shah, Nirav N; Fakhri, Bita; Tessoulin, Benoit; Ma, Shuo; Jagadeesh, Deepa; Lech-Maranda, Ewa; Coombs, Catherine C; Patel, Manish R; Rhodes, Joanna M; Ujjani, Chaitra; Hoffmann, Marc S; Cheah, Chan Y; Munir, Talha; Lewis, David; Scarfò, Lydia; Eyre, Toby A; Alencar, Alvaro; Cohen, Jonathon B; Zelenetz, Andrew D; Tsai, Donald E; Li, Mei; Bian, Yuanyuan; Abada, Paolo; Balbas, Minna; Zinzani, Pier Luigi

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study

Pirtobrutinib,一种高选择性、非共价(可逆)BTKi,用于治疗复发/难治性滤泡性淋巴瘤:BRUIN 1/2期研究

Shah, Nirav N; Zinzani, Pier Luigi; Wang, Michael; Nasta, Sunita D; Lech-Maranda, Ewa; Ogawa, Yoshiaki; Fakhri, Bita; Kuss, Bryone; Miyashita, Kaname; Patel, Krish; Coombs, Catherine C; Ma, Shuo; Patel, Manish R; Barve, Minal A; Tessoulin, Benoit; Stathis, Anastasios; Ennishi, Daisuke; Hashimoto, Daigo; Kojima, Kensuke; Zelenetz, Andrew D; Cohen, Jonathon B; Vose, Julie M; Maddocks, Kami J; Munir, Talha; Sun, Fangfang; Bian, Yuanyuan; Balbas, Minna; Tsai, Donald E; Abada, Paolo; Cheah, Chan Y

Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis

套细胞淋巴瘤CAR-T细胞疗法后疾病进展的治疗及预后:一项多中心分析

Epstein-Peterson, Zachary D; Lionel, Anath C; Joseph, Ashlee; Drill, Esther; Atallah-Yunes, Suheil Albert; Brooks, Taylor R; Chong, Elise A; Chong, Emeline R; Dela Cruz, Jamie; Frank, Matthew J; Ip, Andrew; Iqbal, Madiha; Jacobson, Caron A; Kamdar, Manali K; Karmali, Reem; Beyar-Katz, Ofrat; Maddocks, Kami J; Matasar, Matthew J; McLoughlin, Daniel; Merryman, Reid W; Munoz, Javier L; Navalekar, Rohini; Rhodes, Joanna; Riedell, Peter A; Ryan, Christine E; Salles, Gilles; Sauter, Craig S; Sawalha, Yazeed; Sharma, Samanvaya; Shouval, Roni; Shukla, Navika; Therwhanger, Dylan; van Besien, Herman; Varon, Ben; Wang, Yucai; Yamshon, Samuel; Zelenetz, Andrew D; Palomba, Maria Lia; Jain, Preetesh; Kumar, Anita

Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study

Tafasitab治疗复发或难治性弥漫性大B细胞淋巴瘤患者:II期L-MIND研究的最终5年疗效和安全性结果

Duell, Johannes; Abrisqueta, Pau; Andre, Marc; Gaidano, Gianluca; Gonzales-Barca, Eva; Jurczak, Wojciech; Kalakonda, Nagesh; Liberati, Anna Marina; Maddocks, Kami J; Menne, Tobias; Nagy, Zsolt; Tournilhac, Olivier; Kuffer, Christian; Bakuli, Abhishek; Amin, Aasim; Gurbanov, Konstantin; Salles, Gilles

Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study

局限期浆母细胞淋巴瘤患者的预后:一项多中心回顾性研究

Hess, Brian T; Giri, Anshu; Park, Yeonhee; Patel, Krina K; Link, Brian K; Nowakowski, Grzegorz S; Maliske, Seth M; Fortin, Sonia; Chavez, Julio C; Saeed, Hayder; Hill, Brian T; Mejia Garcia, Alex V; Maddocks, Kami J; Hanel, Walter; Wagner-Johnston, Nina D; Messmer, Marcus R; Kahl, Brad S; Watkins, Marcus; Alderuccio, Juan Pablo; Lossos, Izidore S; Nathan, Sunita; Orellana-Noia, Victor M; Portell, Craig A; Landsburg, Daniel J; Ayers, Emily C; Castillo, Jorge J

Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma

母细胞样和多形性变异型套细胞淋巴瘤患者的预后

Gerson, James N; Handorf, Elizabeth; Villa, Diego; Gerrie, Alina S; Chapani, Parv; Li, Shaoying; Medeiros, L Jeffrey; Wang, Michael; Cohen, Jonathon B; Churnetski, Michael; Hill, Brian T; Sawalha, Yazeed; Hernandez-Ilizaliturri, Francisco J; Kothari, Shalin; Vose, Julie M; Bast, Martin; Fenske, Timothy; Rao Gari, Swapna Narayana; Maddocks, Kami J; Bond, David; Bachanova, Veronika; Kolla, Bhaskar; Chavez, Julio; Shah, Bijal; Lansigan, Frederick; Burns, Timothy; Donovan, Alexandra M; Wagner-Johnston, Nina; Messmer, Marcus; Mehta, Amitkumar; Anderson, Jennifer K; Reddy, Nishitha; Kovach, Alexandra E; Landsburg, Daniel J; Glenn, Martha; Inwards, David J; Ristow, Kay; Karmali, Reem; Kaplan, Jason B; Caimi, Paolo F; Rajguru, Saurabh; Evens, Andrew; Klein, Andreas; Umyarova, Elvira; Pulluri, Bhargavi; Amengual, Jennifer E; Lue, Jennifer K; Diefenbach, Catherine; Fisher, Richard I; Barta, Stefan K

Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapy

选择性抑制接受B细胞靶向治疗的癌症患者体内新产生的SARS-CoV-2疫苗抗体反应

Azar, Joseph H; Evans, John P; Sikorski, Madison H; Chakravarthy, Karthik B; McKenney, Selah; Carmody, Ian; Zeng, Cong; Teodorescu, Rachael; Song, No-Joon; Hamon, Jamie L; Bucci, Donna; Velegraki, Maria; Bolyard, Chelsea; Weller, Kevin P; Reisinger, Sarah A; Bhat, Seema A; Maddocks, Kami J; Denlinger, Nathan; Epperla, Narendranath; Gumina, Richard J; Vlasova, Anastasia N; Oltz, Eugene M; Saif, Linda J; Chung, Dongjun; Woyach, Jennifer A; Shields, Peter G; Liu, Shan-Lu; Li, Zihai; Rubinstein, Mark P

Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era

利妥昔单抗时代套细胞淋巴瘤年轻患者和老年患者的诊疗模式及预后多中心分析

Karmali, Reem; Switchenko, Jeffrey M; Goyal, Subir; Shanmugasundaram, Krithika; Churnetski, Michael C; Kolla, Bhaskar; Bachanova, Veronika; Gerson, James N; Barta, Stefan K; Gordon, Max J; Danilov, Alexey V; Grover, Natalie S; Epperla, Narendranath; Mathews, Stephanie; Burkart, Madelyn; Sawalha, Yazeed; Hill, Brian T; Ghosh, Nilanjan; Park, Steven I; Bond, David A; Maddocks, Kami J; Badar, Talha; Fenske, Timothy S; Hamadani, Mehdi; Guo, Jin; Malecek, Mary; Kahl, Brad S; Martin, Peter; Blum, Kristie A; Flowers, Christopher R; Cohen, Jonathon B

Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

tafasitamab (MOR208) 联合来那度胺治疗复发或难治性弥漫性大B细胞淋巴瘤患者的II期L-MIND研究的长期结果

Duell, Johannes; Maddocks, Kami J; González-Barca, Eva; Jurczak, Wojciech; Liberati, Anna Marina; De Vos, Sven; Nagy, Zsolt; Obr, Aleš; Gaidano, Gianluca; Abrisqueta, Pau; Kalakonda, Nagesh; André, Marc; Dreyling, Martin; Menne, Tobias; Tournilhac, Olivier; Augustin, Marinela; Rosenwald, Andreas; Dirnberger-Hertweck, Maren; Weirather, Johannes; Ambarkhane, Sumeet; Salles, Gilles